Hologic’s HOLX acquisition of Biotheranostics in 2021 accelerated its entry into a large, fast-growing oncology adjacency. The business also carries higher margins than the company’s legacy service ...
Hormones control essential processes like growth, metabolism, mood, and reproduction, but when their balance is disrupted, it ...
bioTheranostics, Inc's Breast Cancer Index, a genomic test quantifying the risk of breast cancer recurrence and predicting which patients will likely benefit from extended endocrine therapy, will be ...
I am Jess Bruce Assistant Manager in Transparency Market Research (TMR). TMR is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of ...
New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test, the Leading Biomarker in Personalizing Endocrine Therapy Duration Findings from 11 ...
Concordance and clinical impact of ER, PR, HER2 expression by local and central immunohistochemistry versus RT-PCR in HR+/HER2- early breast cancer (EBC): Results from the ADAPT trial. Rate of medical ...
Hosted on MSN
What to know about endocrine disorders
Endocrine disorders happen when hormone levels are too high or too low. Fatigue and mood changes are common symptoms of many endocrine disorders. Diabetes is the most common endocrine disorder in the ...
Sickle cell disease (SCD) is an autosomal, recessive hemoglobinopathy characterized by hemolytic anemia, intermittent occlusion of small vessels leading to acute and chronic tissue ischemia, and organ ...
dvm360: What can [lecture] attendees learn about concurrent endocrine and dermatological disease?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results